Clinical Trials

160 enrolled

CNS

Brain Neoplasms, Craniopharyngioma

NCT04286386 2026-04-16

Development and Evaluation of a Quantitative HP MRI for Clinical Prostate Cancer Exam

130 enrolled

Prostate Adenocarcinoma

NCT06960889 2026-04-14

A Retrospective Clinical Study Exploring Prognostic Factors in Esophageal Cancer Patients

500 enrolled

Esophageal Neoplasms

NCT04708418 2026-04-13

A Study Evaluating Whether Pembrolizumab Alone or in Combination With CMP-001 Improves Efficacy of Treatment in Patients With Operable Melanoma

60 enrolled

Dermatologic

Melanoma

NCT05710328 2026-04-03

Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial

235 enrolled

Anatomic Stage II Breast Cancer AJCC v8

NCT04503694 2026-03-27

REGINA

72 enrolled

Rectal Neoplasms

NCT05826509 2026-03-27

SUGAR

240 enrolled

Prostatic Neoplasms

NCT01428895 2026-03-06

Femoral Bone Metastases

180 enrolled

Tumor-Agnostic

Neoplasms

NCT02125786 2026-02-24

A Trial of Surgery and Fractionated Re-Irradiation for Recurrent Ependymoma

Phase 1/2 Active not recruiting

68 enrolled 11 charts

Ependymoma

NCT05081609 2026-02-24

IL Believe

320 enrolled

Gynecologic

Uterine Cervical Neoplasms, Neoplasm Metastasis

NCT01946529 2026-02-23

Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors

Phase 1 Active not recruiting

24 enrolled 11 charts

Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor

NCT04606316 2026-02-17

Surgical Nivolumab And Ipilimumab For Recurrent GBM

63 enrolled

CNS

Glioblastoma

NCT06820957 2026-02-17

Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body

Phase 2/3 Active not recruiting

437 enrolled

Sarcoma

Sarcoma, Ewing

NCT05451290 2026-02-12

Camrelizumab Plus Apatinib in Combination With GEMOX (Gemcitabine and Oxaliplatin ) in Patients With Locally Advanced Biliary Tract Cancer

30 enrolled

Advanced Biliary Tract Carcinoma

NCT02926911 2026-01-27

COMET

997 enrolled 16 charts

Carcinoma, Intraductal, Noninfiltrating, Carcinoma, Ductal

NCT06660810 2026-01-15

Neoadjuvant Intralesional Injection of Talimogene Laherparepvec

2 enrolled

Sarcoma

NCT07339488 2026-01-14

ILDR-03

43 enrolled

Esophageal Squamous Cell Carcinoma

NCT05735912 2026-01-13

ERASIN-RCT

Phase 1/2 Active not recruiting

60 enrolled

Endocrine

Insulinoma

NCT06305767 2026-01-13

INTerpath-005

230 enrolled

Parkinson Disease 4, Autosomal Dominant Lewy Body, Urinary Bladder Neoplasms

NCT05278741 2025-12-26

BREAST

32 enrolled

Breast Neoplasms

NCT00929214 2025-12-17

Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients

35 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT01871766 2025-12-17

Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy

115 enrolled

Sarcoma

Rhabdomyosarcoma

NCT01723774 2025-12-09

PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer

84 enrolled 17 charts

Breast Neoplasms

NCT07272356 2025-12-09

Evaluation of Efficacy of Minimally Invasive Local Therapy for Lung Tumors and Its Impact on Breathing Function

68 enrolled

Carcinoma, Non-Small-Cell Lung, Respiratory Aspiration

NCT05882513 2025-12-02

Serplulimab Combined With Chemotherapy in Patients With Resectable Non-small-cell Lung Cancer

36 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05836584 2025-12-01

Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer

240 enrolled

Clinical Stage I Gastric Cancer AJCC v8

NCT06132087 2025-11-25

PROACTIVE: Surgical Resection Outcomes in Locally Advanced and Unresectable Pancreatic Cancer After Neoadjuvant Chemotherapy

2 enrolled

Locally Advanced Pancreatic Adenocarcinoma

NCT03978624 2025-10-15

Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer

20 enrolled 11 charts

Urinary Bladder Neoplasms

NCT03563248 2025-10-01

Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer

168 enrolled

Pancreatic Neoplasms

NCT06124378 2025-09-24

Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer

60 enrolled

Colonic Neoplasms

NCT02981940 2025-09-02

A Study of Abemaciclib in Recurrent Glioblastoma

45 enrolled 10 charts

CNS

Brain Neoplasms, Glioblastoma

NCT03924856 2025-08-28

KEYNOTE-866

907 enrolled

Parkinson Disease 4, Autosomal Dominant Lewy Body, Urinary Bladder Neoplasms

NCT03924895 2025-08-28

KEYNOTE-905

595 enrolled 3 FDA

Urinary Bladder Neoplasms

NCT06027541 2025-08-03

Young Patients With Early Breast Cancer

1,000 enrolled

Phase 2/3 Active not recruiting

Breast Cancer Female

NCT07076693 2025-07-22

Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC）

97 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03725059 2025-07-11

KEYNOTE-756

1,240 enrolled

Breast Neoplasms

NCT04062708 2025-07-08

CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer

38 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04404777 2025-06-17

LERIS

12,000 enrolled

Rectal Neoplasms

NCT03800134 2025-06-11

AEGEAN

825 enrolled 3 FDA